Authors: Karina M. Butler on behalf of the BREATHER trial team
Published in: CROI 2015, Seattle, USA, Feb 23 -26 2015.
Abstract For HIV-1 infected young people (YP) facing lifelong ART, short cycle therapy (SCT) with long-acting agents offers the potential for drug-free weekends, less toxicity and better adherence, as well as cost savings.